1.48 USD
↘ 0.01 (0.66%)LIVE (AS OF 12:52 PM EDT)
Milestone Pharmaceuticals Inc. Common Shares
MISTNASDAQ • USD
Market: OPEN
Open?$1.53
High?$1.56
Low?$1.49
Prev. Close?$1.51
Volume?827.6K
Avg. Volume?2.2M
VWAP?$1.53
Rel. Volume?0.37x
Bid / Ask
Bid?$1.48 × 600
Ask?$1.49 × 1.4K
Spread?$0.01
Midpoint?$1.48
Valuation & Ratios
Market Cap?180.7M
Shares Out?124.5M
Float?104.3M
Float %?87.2%
P/E Ratio?N/A
P/B Ratio?-9.22
EPS?-$0.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Employees
38
Market Cap
180.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-09
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.18Strong
Quick Ratio?9.09Strong
Cash Ratio?3.41Strong
Debt/Equity?-6.95Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?-9.22CHEAP▾
P/S?101.26HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.8CHEAP▾
EV/Sales?137.69HIGH▾
Returns & Efficiency
ROE?348.8%STRONG▾
ROA?-35.3%WEAK▾
Cash Flow & Enterprise
FCF?$-51483000
Enterprise Value?$245.6M
Fundamentals ratios updated end of day